Drug profile · INN
adsorbed cell culture-derived influenza vaccine (h5n1)
ADSORBED CELL CULTURE-DERIVED INFLUENZA VACCINE H5N1 "KITASATO DAIICHI SANKYO"
adsorbed cell culture-derived influenza vaccine (h5n1) (ADSORBED CELL CULTURE-DERIVED INFLUENZA VACCINE H5N1 "KITASATO DAIICHI SANKYO") is an FDA-listed pharmaceutical active ingredient.
Drug details — adsorbed cell culture-derived influenza vaccine (h5n1)
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
adsorbed cell culture-derived influenza vaccine (h5n1) (ADSORBED CELL CULTURE-DERIVED INFLUENZA VACCINE H5N1 "KITASATO DAIICHI SANKYO") is an FDA-listed pharmaceutical active ingredient.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Frequently asked questions
What is adsorbed cell culture-derived influenza vaccine (h5n1)?
adsorbed cell culture-derived influenza vaccine (h5n1) (ADSORBED CELL CULTURE-DERIVED INFLUENZA VACCINE H5N1 "KITASATO DAIICHI SANKYO") is an FDA-listed pharmaceutical active ingredient.
What is the brand name for adsorbed cell culture-derived influenza vaccine (h5n1)?
ADSORBED CELL CULTURE-DERIVED INFLUENZA VACCINE H5N1 "KITASATO DAIICHI SANKYO" is a marketed brand name for adsorbed cell culture-derived influenza vaccine (h5n1). Check FDA Drugs@FDA for the current US label holder and prescribing information.